Brought to you by 
Feinstein, Karolinska license rights to start-up Applied Immunotherapeutics
29 Nov 2021
Executive Summary
The Feinstein Institute for Medical Research and Karolinska Institute granted Applied Immunotherapeutics Inc. (start-up developing treatments for autoimmune and inflammatory diseases) rights to discoveries and intellectual property for use in its drug development activities.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Large Molecule
- Antibodies
-
Large Molecule
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Feinstein, Karolinska license rights to start-up Applied Immunotherapeutics
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice